Tianjin Tianyao Pharmaceuticals Co Ltd (600488) — Cash Flow-to-Debt Ratio
Tianjin Tianyao Pharmaceuticals Co Ltd (600488) has a Cash Flow-to-Debt Ratio of 0.01x as of September 2025, meaning its operating cash flow of CN¥13.19 Million could theoretically repay 0% of its total liabilities (CN¥1.85 Billion) in one year. Explore long-term investment intensity of Tianjin Tianyao Pharmaceuticals Co Ltd to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Tianjin Tianyao Pharmaceuticals Co Ltd Cash Flow-to-Debt Ratio (2000–2024)
Historical debt coverage capacity for Tianjin Tianyao Pharmaceuticals Co Ltd across 25 annual periods. Also explore Tianjin Tianyao Pharmaceuticals Co Ltd assets under control for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Tianjin Tianyao Pharmaceuticals Co Ltd (2000–2024)
Year-by-year debt coverage analysis for Tianjin Tianyao Pharmaceuticals Co Ltd. For market capitalisation and broader financial context, see Tianjin Tianyao Pharmaceuticals Co Ltd (600488) market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.31x | CN¥569.37 Million | CN¥1.81 Billion | ▼ -4.1% |
| 2023 | 0.33x | CN¥783.01 Million | CN¥2.39 Billion | ▲ +45.3% |
| 2022 | 0.23x | CN¥653.52 Million | CN¥2.90 Billion | ▲ +80.0% |
| 2021 | 0.13x | CN¥316.89 Million | CN¥2.53 Billion | ▼ -13.2% |
| 2020 | 0.14x | CN¥346.88 Million | CN¥2.40 Billion | ▼ -12.4% |
| 2019 | 0.16x | CN¥279.37 Million | CN¥1.70 Billion | ▲ +32.2% |
| 2018 | 0.12x | CN¥189.27 Million | CN¥1.52 Billion | ▲ +1865.8% |
| 2017 | -0.01x | CN¥-8.15 Million | CN¥1.15 Billion | ▼ -105.7% |
| 2016 | 0.12x | CN¥63.32 Million | CN¥511.21 Million | ▼ -44.1% |
| 2015 | 0.22x | CN¥129.50 Million | CN¥584.42 Million | ▼ -37.9% |
| 2014 | 0.36x | CN¥178.76 Million | CN¥501.34 Million | ▲ +231.3% |
| 2013 | 0.11x | CN¥84.55 Million | CN¥785.64 Million | ▲ +489.2% |
| 2012 | 0.02x | CN¥13.23 Million | CN¥724.13 Million | ▼ -83.0% |
| 2011 | 0.11x | CN¥78.47 Million | CN¥729.86 Million | ▲ +18.6% |
| 2010 | 0.09x | CN¥116.82 Million | CN¥1.29 Billion | ▼ -77.8% |
| 2009 | 0.41x | CN¥435.13 Million | CN¥1.07 Billion | ▲ +98.5% |
| 2008 | 0.21x | CN¥219.31 Million | CN¥1.07 Billion | ▲ +8.1% |
| 2007 | 0.19x | CN¥162.33 Million | CN¥854.65 Million | ▲ +404.7% |
| 2006 | 0.04x | CN¥50.72 Million | CN¥1.35 Billion | ▲ +132.3% |
| 2005 | -0.12x | CN¥-108.87 Million | CN¥933.43 Million | ▼ -157.2% |
| 2004 | 0.20x | CN¥110.30 Million | CN¥541.10 Million | ▲ +198.1% |
| 2003 | 0.07x | CN¥45.77 Million | CN¥669.25 Million | ▼ -4.2% |
| 2002 | 0.07x | CN¥45.28 Million | CN¥634.50 Million | ▼ -58.4% |
| 2001 | 0.17x | CN¥71.87 Million | CN¥419.39 Million | ▲ +21.5% |
| 2000 | 0.14x | CN¥41.06 Million | CN¥291.03 Million | — |